Memorial Sloan Kettering Cancer Center
ASH 2021 Update on the Safety & Efficacy of Menin Inhibition in MLL-Rearranged and NPM1-Mutant Acute Leukemia: Ph 1 First-in-Human Study of SNDX-5613
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eytan Stein
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Eytan Stein
Login to view comments.
Click here to Login